Company intelligence / Profile preview

MONCYTE Health

Ownership: Private
Development stage: Preclinical

Overview

MONCYTE Health has developed a proprietary diagnostic technology that quantifies individual differences in cellular lipid uptake and storage to help clinicians select more effective personalized treatments for patients with high cholesterol[1][2]. The technology provides insights into why patients respond differently to cholesterol-lowering drugs[2].

Therapeutic areas: Cardiovascular
Modalities: Diagnostic technology
Industry: Metabolite Diagnostics

Partnerships

Pharmaceutical companies developing lipid-lowering treatments[1][3]

Beyond the preview

Go deeper on MONCYTE Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MONCYTE Health.

Explore the full profile